Resources

Ongoing Trials for Drugs in the Prevention and Treatment of COVID-19

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Last Updated: April 22, 2021

Also available in Français

Fighting COVID‑19 in Ontario: The Way Forward

Product: — Science Table

About Coronavirus Epidemiology Public Health Policy Regulation & Policy

covid19-sciencetable.ca Last Updated: April 20, 2021

Strategies to Manage Tocilizumab Supply During the COVID‑19 Pandemic

Product: — Science Table

Drug Interventions Future Planning Treatments

covid19-sciencetable.ca Last Updated: April 19, 2021

Health System Recovery Plans Following Responses for COVID‑19 Waves 2 & 3

Product: — Evidence Synthesis Network

Public Health Policy Regulation & Policy

esnetwork.ca Last Updated: April 14, 2021

Impacts of Nighttime Curfews on Mobility and Transmission of COVID-19

Product: — Evidence Synthesis Network

Community Prevention & Transmission Public Prevention

esnetwork.ca Last Updated: April 14, 2021

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Treatments

covid19-sciencetable.ca Last Updated: April 6, 2021

Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) following AstraZeneca COVID‑19 Vaccination: Interim Guidance for Healthcare Professionals in Emergency Department and Inpatient Settings

Product: — Science Table

Clinicians Healthcare Workers Regulation & Policy Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: April 2, 2021

Infection Control and Public Health Measures in Long-Term Care and Retirement Homes Following COVID‑19 Vaccination of Residents

Product: — Evidence Synthesis Network

Long-term & Community Care Long-term Care Public Health Policy Regulation & Policy

esnetwork.ca Last Updated: April 1, 2021

Tocilizumab and Sarilumab: Evidence Review and Appraisal

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Last Updated: March 25, 2021

Also available in Français

Casirivimab-Imdevimab for COVID-19: Evidence Review and Appraisal

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Last Updated: March 25, 2021

Also available in Français